Evidence map›Paper›PMID 40258069›Full record

ArticleNano letters2025

Integrated Methodology from Synthesis to

Yanqiu Ye, Guohui Huang, Wei Zhang, Jiasheng Wu, Jianhao Wu, Yingxin Li, Xiaoxia Zhou, Jianbo Jia, Zengchun Xie, Bing Yan and 4 more

Abstract read
In one paragraph

Article in Nano letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yanqiu YeGuangzhou Key Laboratory for Research and Development of Nano-Biomedical Technology for Diagnosis and Therapy, Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, Department of Oncology & Translational Medicine Center, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510260, P.R. China.
Guohui HuangGuangzhou Key Laboratory for Research and Development of Nano-Biomedical Technology for Diagnosis and Therapy, Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, Department of Oncology & Translational Medicine Center, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510260, P.R. China.
Wei ZhangCentre for BioNano Interactions, School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland.
Jiasheng WuGuangzhou Key Laboratory for Research and Development of Nano-Biomedical Technology for Diagnosis and Therapy, Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, Department of Oncology & Translational Medicine Center, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510260, P.R. China.
Jianhao WuGuangzhou Key Laboratory for Research and Development of Nano-Biomedical Technology for Diagnosis and Therapy, Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, Department of Oncology & Translational Medicine Center, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510260, P.R. China.
Yingxin LiGuangzhou Key Laboratory for Research and Development of Nano-Biomedical Technology for Diagnosis and Therapy, Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, Department of Oncology & Translational Medicine Center, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510260, P.R. China.
Xiaoxia ZhouInstitute of Environmental Research at Greater Bay Area, Key Laboratory for Water Quality and Conservation of the Pearl River Delta, Ministry of Education, Guangzhou University, Guangzhou 510006, P.R. China.
Jianbo JiaInstitute of Environmental Research at Greater Bay Area, Key Laboratory for Water Quality and Conservation of the Pearl River Delta, Ministry of Education, Guangzhou University, Guangzhou 510006, P.R. China.ORCID 0000-0002-1703-6734
Zengchun XieCentre for BioNano Interactions, School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland.
Bing YanInstitute of Environmental Research at Greater Bay Area, Key Laboratory for Water Quality and Conservation of the Pearl River Delta, Ministry of Education, Guangzhou University, Guangzhou 510006, P.R. China.
Kenneth A DawsonGuangzhou Key Laboratory for Research and Development of Nano-Biomedical Technology for Diagnosis and Therapy, Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, Department of Oncology & Translational Medicine Center, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510260, P.R. China.ORCID 0000-0002-0568-6588
Jingqi ChenGuangzhou Key Laboratory for Research and Development of Nano-Biomedical Technology for Diagnosis and Therapy, Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, Department of Oncology & Translational Medicine Center, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510260, P.R. China.
Yi-Feng WangGuangzhou Key Laboratory for Research and Development of Nano-Biomedical Technology for Diagnosis and Therapy, Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, Department of Oncology & Translational Medicine Center, The Second Affiliated Hospital & the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510260, P.R. China.ORCID 0009-0003-9951-8108
Yan YanCentre for BioNano Interactions, School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland.ORCID 0000-0003-2938-4063

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new integrated tunable microfluidic particle synthesis and shape population analysis workflow allows us to study the immunological readouts for even highly complex shaped nanoparticles. Using this approach, we demonstrate that some gold nanoparticles, when injected parenterally, are taken up by axillary and brachial lymph nodes. We then show that specific nanoparticle shapes influence the primary structure of the T cell receptor, inducing changes in hypervariable complementary-determining regions (CDRs) and increasing the clonal diversity of the T cell receptor repertoires. These same particles were previously found to modify cellular epigenomes and elevate the level of autoantibodies. Our results are consistent with other emerging reports that precisely controlled nanoarchitectural features are recognized and captured in multiple tiers of biology, with potential implications for vaccine adjuvant design. Our conclusions may also be relevant to an extensive legacy of poorly understood epidemiological studies, suggesting links between some pollutant particulates and complex forms of immune dysregulation and autoimmune diseases.

Indexed as

GoldMetal NanoparticlesReceptors, Antigen, T-CellAnimalsComplementarity Determining RegionsHumansLymph NodesMiceComplementarity Determining RegionsGoldReceptors, Antigen, T-CellClonal diversityNanoscale biological recognitionNanoscale shapeT cell receptor repertoireVaccine adjuvants

Identifiers

PMID40258069
PMCPMC12046591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.